Showing 1 - 12 of 15 results for "05872"
1 Product
- ReferenceH. Kim et al. ( 2019) Stem cell reports 12 5 890--905
Pluripotent Stem Cell-Derived Cerebral Organoids Reveal Human Oligodendrogenesis with Dorsal and Ventral Origins.
The process of oligodendrogenesis has been relatively well delineated in the rodent brain. However, it remains unknown whether analogous developmental processes are manifested in the human brain. Here we report oligodendrogenesis in forebrain organoids, generated by using OLIG2-GFP knockin human pluripotent stem cell (hPSC) reporter lines. OLIG2/GFP exhibits distinct temporal expression patterns in ventral forebrain organoids (VFOs) versus dorsal forebrain organoids (DFOs). Interestingly, oligodendrogenesis can be induced in both VFOs and DFOs after neuronal maturation. Assembling VFOs and DFOs to generate fused forebrain organoids (FFOs) promotes oligodendroglia maturation. Furthermore, dorsally derived oligodendroglial cells outcompete ventrally derived oligodendroglia and become dominant in FFOs after long-term culture. Thus, our organoid models reveal human oligodendrogenesis with ventral and dorsal origins. These models will serve to study the phenotypic and functional differences between human ventrally and dorsally derived oligodendroglia and to reveal mechanisms of diseases associated with cortical myelin defects. View PublicationCatalog #: Product Name: 05872 ReLeSR™ 05790 BrainPhys™ Neuronal Medium 85850 mTeSR™1 Catalog #: 05872 Product Name: ReLeSR™ Catalog #: 05790 Product Name: BrainPhys™ Neuronal Medium Catalog #: 85850 Product Name: mTeSR™1 - Product Information Sheet
Catalog #: Lot #: Language Product Name: 05872 All English ReLeSR™ 05873 All English ReLeSR™ Catalog #: 05872 Lot #: All Language English Product Name: ReLeSR™ Catalog #: 05873 Lot #: All Language English Product Name: ReLeSR™ - ReferenceS. Bell et al. (JUL 2018) Stem cell reports 11 1 183--196
Disruption of GRIN2B Impairs Differentiation in Human Neurons.
Heterozygous loss-of-function mutations in GRIN2B, a subunit of the NMDA receptor, cause intellectual disability and language impairment. We developed clonal models of GRIN2B deletion and loss-of-function mutations in a region coding for the glutamate binding domain in human cells and generated neurons from a patient harboring a missense mutation in the same domain. Transcriptome analysis revealed extensive increases in genes associated with cell proliferation and decreases in genes associated with neuron differentiation, a result supported by extensive protein analyses. Using electrophysiology and calcium imaging, we demonstrate that NMDA receptors are present on neural progenitor cells and that human mutations in GRIN2B can impair calcium influx and membrane depolarization even in a presumed undifferentiated cell state, highlighting an important role for non-synaptic NMDA receptors. It may be this function, in part, which underlies the neurological disease observed in patients with GRIN2B mutations. View PublicationCatalog #: Product Name: 05833 STEMdiff™ Neural Progenitor Medium 05872 ReLeSR™ 07174 Gentle Cell Dissociation Reagent 05790 BrainPhys™ Neuronal Medium 85850 mTeSR™1 Catalog #: 05833 Product Name: STEMdiff™ Neural Progenitor Medium Catalog #: 05872 Product Name: ReLeSR™ Catalog #: 07174 Product Name: Gentle Cell Dissociation Reagent Catalog #: 05790 Product Name: BrainPhys™ Neuronal Medium Catalog #: 85850 Product Name: mTeSR™1 - ReferenceBershteyn M et al. (APR 2017) Cell stem cell 20 4 435--449.e4
Human iPSC-Derived Cerebral Organoids Model Cellular Features of Lissencephaly and Reveal Prolonged Mitosis of Outer Radial Glia.
Classical lissencephaly is a genetic neurological disorder associated with mental retardation and intractable epilepsy, and Miller-Dieker syndrome (MDS) is the most severe form of the disease. In this study, to investigate the effects of MDS on human progenitor subtypes that control neuronal output and influence brain topology, we analyzed cerebral organoids derived from control and MDS-induced pluripotent stem cells (iPSCs) using time-lapse imaging, immunostaining, and single-cell RNA sequencing. We saw a cell migration defect that was rescued when we corrected the MDS causative chromosomal deletion and severe apoptosis of the founder neuroepithelial stem cells, accompanied by increased horizontal cell divisions. We also identified a mitotic defect in outer radial glia, a progenitor subtype that is largely absent from lissencephalic rodents but critical for human neocortical expansion. Our study, therefore, deepens our understanding of MDS cellular pathogenesis and highlights the broad utility of cerebral organoids for modeling human neurodevelopmental disorders. View PublicationCatalog #: Product Name: 05872 ReLeSR™ 85850 mTeSR™1 07920 ACCUTASE™ Catalog #: 05872 Product Name: ReLeSR™ Catalog #: 85850 Product Name: mTeSR™1 Catalog #: 07920 Product Name: ACCUTASE™ - ReferenceWu X et al. (JAN 2018) Cell 172 3 423--438.e25
Intrinsic Immunity Shapes Viral Resistance of Stem Cells.
Stem cells are highly resistant to viral infection compared to their differentiated progeny; however, the mechanism is mysterious. Here, we analyzed gene expression in mammalian stem cells and cells at various stages of differentiation. We find that, conserved across species, stem cells express a subset of genes previously classified as interferon (IFN) stimulated genes (ISGs) but that expression is intrinsic, as stem cells are refractory to interferon. This intrinsic ISG expression varies in a cell-type-specific manner, and many ISGs decrease upon differentiation, at which time cells become IFN responsive, allowing induction of a broad spectrum of ISGs by IFN signaling. Importantly, we show that intrinsically expressed ISGs protect stem cells against viral infection. We demonstrate the in vivo importance of intrinsic ISG expression for protecting stem cells and their differentiation potential during viral infection. These findings have intriguing implications for understanding stem cell biology and the evolution of pathogen resistance. View PublicationCatalog #: Product Name: 02691 StemSpan™ CD34+ Expansion Supplement (10X) 04434 MethoCult™ H4434 Classic 05110 STEMdiff™ Definitive Endoderm Kit 05711 NeuroCult™ SM1 Neuronal Supplement 05872 ReLeSR™ 72052 CHIR99021 72302 Y-27632 (Dihydrochloride) 70039 Human Peripheral Blood Plasma, Frozen 60062 Anti-Human SSEA-4 Antibody, Clone MC-813-70 60045 Anti-Human CD90 Antibody, Clone 5E10 Catalog #: 02691 Product Name: StemSpan™ CD34+ Expansion Supplement (10X) Catalog #: 04434 Product Name: MethoCult™ H4434 Classic Catalog #: 05110 Product Name: STEMdiff™ Definitive Endoderm Kit Catalog #: 05711 Product Name: NeuroCult™ SM1 Neuronal Supplement Catalog #: 05872 Product Name: ReLeSR™ Catalog #: 72052 Product Name: CHIR99021 Catalog #: 72302 Product Name: Y-27632 (Dihydrochloride) Catalog #: 70039 Product Name: Human Peripheral Blood Plasma, Frozen Catalog #: 60062 Product Name: Anti-Human SSEA-4 Antibody, Clone MC-813-70 Catalog #: 60045 Product Name: Anti-Human CD90 Antibody, Clone 5E10 - ReferenceWerner A et al. (SEP 2015) Nature 525 7570 523--527
Cell-fate determination by ubiquitin-dependent regulation of translation
Metazoan development depends on the accurate execution of differentiation programs that allow pluripotent stem cells to adopt specific fates. Differentiation requires changes to chromatin architecture and transcriptional networks, yet whether other regulatory events support cell-fate determination is less well understood. Here we identify the ubiquitin ligase CUL3 in complex with its vertebrate-specific substrate adaptor KBTBD8 (CUL3(KBTBD8)) as an essential regulator of human and Xenopus tropicalis neural crest specification. CUL3(KBTBD8) monoubiquitylates NOLC1 and its paralogue TCOF1, the mutation of which underlies the neurocristopathy Treacher Collins syndrome. Ubiquitylation drives formation of a TCOF1-NOLC1 platform that connects RNA polymerase I with ribosome modification enzymes and remodels the translational program of differentiating cells in favour of neural crest specification. We conclude that ubiquitin-dependent regulation of translation is an important feature of cell-fate determination. View PublicationCatalog #: Product Name: 05872 ReLeSR™ 34811 AggreWell™800 05835 STEMdiff™ Neural Induction Medium 07920 ACCUTASE™ Catalog #: 05872 Product Name: ReLeSR™ Catalog #: 34811 Product Name: AggreWell™800 Catalog #: 05835 Product Name: STEMdiff™ Neural Induction Medium Catalog #: 07920 Product Name: ACCUTASE™ - ReferenceLorzadeh A et al. (NOV 2016) Cell reports 17 8 2112--2124
Nucleosome Density ChIP-Seq Identifies Distinct Chromatin Modification Signatures Associated with MNase Accessibility.
Nucleosome position, density, and post-translational modification are widely accepted components of mechanisms regulating DNA transcription but still incompletely understood. We present a modified native ChIP-seq method combined with an analytical framework that allows MNase accessibility to be integrated with histone modification profiles. Application of this methodology to the primitive (CD34+) subset of normal human cord blood cells enabled genomic regions enriched in one versus two nucleosomes marked by histone 3 lysine 4 trimethylation (H3K4me3) and/or histone 3 lysine 27 trimethylation (H3K27me3) to be associated with their transcriptional and DNA methylation states. From this analysis, we defined four classes of promoter-specific profiles and demonstrated that a majority of bivalent marked promoters are heterogeneously marked at a single-cell level in this primitive cell type. Interestingly, extension of this approach to human embryonic stem cells revealed an altered relationship between chromatin modification state and nucleosome content at promoters, suggesting developmental stage-specific organization of histone methylation states. View PublicationCatalog #: Product Name: 05872 ReLeSR™ 15086 Complete Kit for Human Whole Blood CD34+ Cells 85850 mTeSR™1 Catalog #: 05872 Product Name: ReLeSR™ Catalog #: 15086 Product Name: Complete Kit for Human Whole Blood CD34+ Cells Catalog #: 85850 Product Name: mTeSR™1 - ReferenceOrellana DI et al. (OCT 2016) EMBO molecular medicine 8 10 1197--1211
Coenzyme A corrects pathological defects in human neurons of PANK2-associated neurodegeneration.
Pantothenate kinase-associated neurodegeneration (PKAN) is an early onset and severely disabling neurodegenerative disease for which no therapy is available. PKAN is caused by mutations in PANK2, which encodes for the mitochondrial enzyme pantothenate kinase 2. Its function is to catalyze the first limiting step of Coenzyme A (CoA) biosynthesis. We generated induced pluripotent stem cells from PKAN patients and showed that their derived neurons exhibited premature death, increased ROS production, mitochondrial dysfunctions-including impairment of mitochondrial iron-dependent biosynthesis-and major membrane excitability defects. CoA supplementation prevented neuronal death and ROS formation by restoring mitochondrial and neuronal functionality. Our findings provide direct evidence that PANK2 malfunctioning is responsible for abnormal phenotypes in human neuronal cells and indicate CoA treatment as a possible therapeutic intervention. View PublicationCatalog #: Product Name: 05872 ReLeSR™ 85850 mTeSR™1 Catalog #: 05872 Product Name: ReLeSR™ Catalog #: 85850 Product Name: mTeSR™1 - ReferenceRobinson M et al. (AUG 2016) Stem Cell Reviews and Reports 12 4 476--483
Functionalizing Ascl1 with Novel Intracellular Protein Delivery Technology for Promoting Neuronal Differentiation of Human Induced Pluripotent Stem Cells
Pluripotent stem cells can become any cell type found in the body. Accordingly, one of the major challenges when working with pluripotent stem cells is producing a highly homogenous population of differentiated cells, which can then be used for downstream applications such as cell therapies or drug screening. The transcription factor Ascl1 plays a key role in neural development and previous work has shown that Ascl1 overexpression using viral vectors can reprogram fibroblasts directly into neurons. Here we report on how a recombinant version of the Ascl1 protein functionalized with intracellular protein delivery technology (Ascl1-IPTD) can be used to rapidly differentiate human induced pluripotent stem cells (hiPSCs) into neurons. We first evaluated a range of Ascl1-IPTD concentrations to determine the most effective amount for generating neurons from hiPSCs cultured in serum free media. Next, we looked at the frequency of Ascl1-IPTD supplementation in the media on differentiation and found that one time supplementation is sufficient enough to trigger the neural differentiation process. Ascl1-IPTD was efficiently taken up by the hiPSCs and enabled rapid differentiation into TUJ1-positive and NeuN-positive populations with neuronal morphology after 8 days. After 12 days of culture, hiPSC-derived neurons produced by Ascl1-IPTD treatment exhibited greater neurite length and higher numbers of branch points compared to neurons derived using a standard neural progenitor differentiation protocol. This work validates Ascl1-IPTD as a powerful tool for engineering neural tissue from pluripotent stem cells. View PublicationCatalog #: Product Name: 05832 STEMdiff™ Neural Rosette Selection Reagent 05833 STEMdiff™ Neural Progenitor Medium 05838 STEMdiff™ Neural Progenitor Freezing Medium 05872 ReLeSR™ 07174 Gentle Cell Dissociation Reagent 07180 Vitronectin XF™ 36254 DMEM/F-12 with 15 mM HEPES 07930 CryoStor® CS10 05835 STEMdiff™ Neural Induction Medium 08581 STEMdiff™ SMADi Neural Induction Kit Catalog #: 05832 Product Name: STEMdiff™ Neural Rosette Selection Reagent Catalog #: 05833 Product Name: STEMdiff™ Neural Progenitor Medium Catalog #: 05838 Product Name: STEMdiff™ Neural Progenitor Freezing Medium Catalog #: 05872 Product Name: ReLeSR™ Catalog #: 07174 Product Name: Gentle Cell Dissociation Reagent Catalog #: 07180 Product Name: Vitronectin XF™ Catalog #: 36254 Product Name: DMEM/F-12 with 15 mM HEPES Catalog #: 07930 Product Name: CryoStor® CS10 Catalog #: 05835 Product Name: STEMdiff™ Neural Induction Medium Catalog #: 08581 Product Name: STEMdiff™ SMADi Neural Induction Kit - ReferenceLowe A et al. (MAY 2016) Stem Cell Reports 6 5 743--756
Intercellular Adhesion-Dependent Cell Survival and ROCK-Regulated Actomyosin-Driven Forces Mediate Self-Formation of a Retinal Organoid
In this study we dissected retinal organoid morphogenesis in human embryonic stem cell (hESC)-derived cultures and established a convenient method for isolating large quantities of retinal organoids for modeling human retinal development and disease. Epithelialized cysts were generated via floating culture of clumps of Matrigel/hESCs. Upon spontaneous attachment and spreading of the cysts, patterned retinal monolayers with tight junctions formed. Dispase-mediated detachment of the monolayers and subsequent floating culture led to self-formation of retinal organoids comprising patterned neuroretina, ciliary margin, and retinal pigment epithelium. Intercellular adhesion-dependent cell survival and ROCK-regulated actomyosin-driven forces are required for the self-organization. Our data supports a hypothesis that newly specified neuroretina progenitors form characteristic structures in equilibrium through minimization of cell surface tension. In long-term culture, the retinal organoids autonomously generated stratified retinal tissues, including photoreceptors with ultrastructure of outer segments. Our system requires minimal manual manipulation, has been validated in two lines of human pluripotent stem cells, and provides insight into optic cup invagination in vivo. View PublicationCatalog #: Product Name: 05872 ReLeSR™ 85850 mTeSR™1 Catalog #: 05872 Product Name: ReLeSR™ Catalog #: 85850 Product Name: mTeSR™1 - ReferenceLi C-S et al. (MAR 2016) Biomaterials 83 194--206
Fibromodulin reprogrammed cells: A novel cell source for bone regeneration.
Pluripotent or multipotent cell-based therapeutics are vital for skeletal reconstruction in non-healing critical-sized defects since the local endogenous progenitor cells are not often adequate to restore tissue continuity or function. However, currently available cell-based regenerative strategies are hindered by numerous obstacles including inadequate cell availability, painful and invasive cell-harvesting procedures, and tumorigenesis. Previously, we established a novel platform technology for inducing a quiescent stem cell-like stage using only a single extracellular proteoglycan, fibromodulin (FMOD), circumventing gene transduction. In this study, we further purified and significantly increased the reprogramming rate of the yield multipotent FMOD reprogrammed (FReP) cells. We also exposed the 'molecular blueprint' of FReP cell osteogenic differentiation by gene profiling. Radiographic analysis showed that implantation of FReP cells into a critical-sized SCID mouse calvarial defect, contributed to the robust osteogenic capability of FReP cells in a challenging clinically relevant traumatic scenario in vivo. The persistence, engraftment, and osteogenesis of transplanted FReP cells without tumorigenesis in vivo were confirmed by histological and immunohistochemical staining. Taken together, we have provided an extended potency, safety, and molecular profile of FReP cell-based bone regeneration. Therefore, FReP cells present a high potential for cellular and gene therapy products for bone regeneration. View PublicationCatalog #: Product Name: 05872 ReLeSR™ 05893 AggreWell™ EB Formation Medium 85850 mTeSR™1 Catalog #: 05872 Product Name: ReLeSR™ Catalog #: 05893 Product Name: AggreWell™ EB Formation Medium Catalog #: 85850 Product Name: mTeSR™1 - ReferenceCaiazzo M et al. (MAR 2016) Nature Materials 15 3 344--352
Defined three-dimensional microenvironments boost induction of pluripotency
Since the discovery of induced pluripotent stem cells (iPSCs), numerous approaches have been explored to improve the original protocol, which is based on a two-dimensional (2D) cell-culture system. Surprisingly, nothing is known about the effect of a more biologically faithful 3D environment on somatic-cell reprogramming. Here, we report a systematic analysis of how reprogramming of somatic cells occurs within engineered 3D extracellular matrices. By modulating microenvironmental stiffness, degradability and biochemical composition, we have identified a previously unknown role for biophysical effectors in the promotion of iPSC generation. We find that the physical cell confinement imposed by the 3D microenvironment boosts reprogramming through an accelerated mesenchymal-to-epithelial transition and increased epigenetic remodelling. We conclude that 3D microenvironmental signals act synergistically with reprogramming transcription factors to increase somatic plasticity. View PublicationCatalog #: Product Name: 05872 ReLeSR™ 85850 mTeSR™1 Catalog #: 05872 Product Name: ReLeSR™ Catalog #: 85850 Product Name: mTeSR™1
1 Product
Shop By
Filter Results
- Resource Type
- Product Information Sheet 2 items
- Reference 12 items
- Safety Data Sheet 1 item
- Area of Interest
- Immunology 1 item
- Neuroscience 3 items
- Stem Cell Biology 8 items
- Brand
- AggreWell 1 item
- BrainPhys 2 items
- EasySep 1 item
- MethoCult 1 item
- NeuroCult 1 item
- STEMdiff 2 items
- TeSR 9 items
- Cell Type
- Hematopoietic Stem and Progenitor Cells 1 item
- Neural Cells, PSC-Derived 2 items
- Neural Stem and Progenitor Cells 2 items
- Neurons 2 items
- Pluripotent Stem Cells 7 items